Position
Fidelity in Oric Pharmaceuticals, Inc.
Back to the book · All holders of ORIC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$4.48M$12.67 → $10.83
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.48M | $20.3M | — | — | — | 0.0% |
| Q1 2026 | 2.43M | $30.8M | $12.67 | $10.9M | −$366.8K | 0.0% |
| Q2 2026 | 2.64M | $28.5M | $10.83 | −$4.48M | $2.18M | 0.0% |